Zacks Investment Research
07 Aug 2026, 03:36 UTC · 1h ago
CVRx (CVRX) Reports Q2 Loss, Beats Revenue Estimates
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Zacks Investment Research
07 Aug 2026, 03:36 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
CVRx reported a quarterly loss of $0.53 per share, missing the Zacks Consensus Estimate of $0.52. — An earnings miss, even a slight one, generally creates negative short-term pressure on a stock's price.
-0.30CVRx reported quarterly revenues of $15.71 million, surpassing the Zacks Consensus Estimate by 0.40%. — Revenue growth and a beat on top-line estimates indicate positive demand for the company's medical devices.
+0.20CVRx year-over-year revenue increased to $15.71 million from $13.59 million in the prior year's quarter. — Year-over-year revenue growth demonstrates a positive trajectory in the company's scale of operations.
+0.20Which stocks this story touches
Continue reading
6 related stories
Top 3 movers · tap to explore
The company reported a quarterly loss that missed consensus estimates and has underperformed the S&P 500 significantly this year.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Zacks Investment Research
1h ago
